云南省肿瘤医院2005年-2014年肺癌流行病学特征变化趋势分析

BACKGROUND AND OBJECTIVE: Yunnan is a country with a high incidence of lung cancer in China and all over the world, and its morbidity and mortality are still rising. With changes in lifestyle and environment, the clinical epidemiological characteristics of lung cancer are converting. However, the trend of clinical characteristics of lung cancer in Yunnan has not been reported in the past 10 years, and we should start further research. The aim of this study was to explore the clinical characteristics and changes of lung cancer in Yunnan from 2005 to 2014, and to provide a theoretical basis for lung cancer prevention and treatment in this region. METHODS: A retrospective survey was used to extract the cases of lung cancer patients who were treated in our hospital from 2005 to 2014 by simple random sampling. The sociodemographic and clinicopathological characteristics of the patients were extracted by using a unified and standardized questionnaire. And the statistical analysis of the data was performed. RESULTS: A total of 1, 000 patients with lung cancer were enrolled, with an average age of (58.1±10.1) years, and the ratio of male to female was 3.08/1.00. The proportion of male patients decreased from 75.0% in 2005 to 66.0% in 2014, while female patients increased from 25.0% to 34.0% (P=0.007). The proportion of patients aged ≥60 years increased from 30.0% in 2005 to 39.0% in 2014, and the proportion of patients under 60 years of age decreased, but there was no statistical difference (P=0.532). The proportion of patients with lower levels of education (primary or junior high school) increased from 36.0% to 66.0% (P < 0.001). The proportion of smokers decreased from 71.0% to 47.0%, and the number of non-smokers increased from 29.0% to 52.0% (P=0.003). The patients with advanced lung cancer (Ⅲb-Ⅳ) increased from 20.0% to 54.0%, while the proportion of stage Ⅱ-Ⅲa decreased from 62.0% to 24.0% (P=0.002). The proportion of adenocarcinoma increased from 36.0% to 61.0%, while squamous cell carcinoma decreased from 32.0% to 27.0% (P < 0.001). Chest X-ray applications decreased from 91.0% to 58.0% (P < 0.001), while chest computed tomography (CT) usage increased from 46.0% to 89.0% (P < 0.001). Head magnetic resonance imaging (MRI) usage increased from 1.0% to 15.0% (P < 0.001). The bone scan increased from 35.0% to 78.0% (P < 0.001). The positron emission tomography-CT (PET-CT) inspection technique increased significantly from 0.0% to 17.0%. Chemotherapy (P=0.67) and surgery (P=0.78) were the most common treatments and the treatments were unchanged over the past 10 years. CONCLUSION: The proportion of female patients increased, the clinical stage was late, and the pathological type transformation was a major challenge in the prevention and treatment of lung cancer in Yunnan. Despite major changes in sociodemographic and clinicopathological features, the choice of primary treatment modalities has not changed, and further research is needed.